Mechanistic Insight into How PEGylation Reduces the Efficacy of PH-Sensitive Liposomes from Molecular Dynamics Simulations
Overview
Affiliations
Liposome-based drug delivery systems composed of DOPE stabilized with cholesteryl hemisuccinate (CHMS) have been proposed as a drug delivery mechanism with pH-triggered release as the anionic form (CHSa) is protonated (CHS) at reduced pH; PEGylation is known to decrease this pH sensitivity. In this manuscript, we set out to use molecular dynamics (MD) simulations with a model with all-atom resolution to provide insight into why incorporation of poly(ethyleneglycol) (PEG) into DOPE-CHMS liposomes reduces their pH sensitivity; we also address two additional questions: (1) How CHSa stabilizes DOPE bilayers into a lamellar conformation at a physiological pH of 7.4? and (2) how the change from CHSa to CHS at acidic pH triggers the destabilization of DOPE bilayers? We found that (A) CHSa stabilizes the DOPE lipid membrane by increasing the hydrophilicity of the bilayer surface, (B) when CHSa changes to CHS by pH reduction, DOPE bilayers are destabilized due to a reduction in bilayer hydrophilicity and a reduction in the area per lipid, and (C) PEG stabilizes DOPE bilayers into the lamellar phase, thus reducing the pH sensitivity of the liposomes by increasing the area per lipid through penetration into the bilayer, which is our main focus.
Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery.
Paloncyova M, Valerio M, Dos Santos R, Kuhrova P, Srejber M, cechova P Mol Pharm. 2025; 22(3):1110-1141.
PMID: 39879096 PMC: 11881150. DOI: 10.1021/acs.molpharmaceut.4c00744.
Nikolic I, dokovic J, Mehn D, Guerrini G, Savic S, Jordan O Drug Deliv Transl Res. 2025; .
PMID: 39779651 DOI: 10.1007/s13346-024-01776-7.
Pandey P, Arya D, Deepak P, Ali D, Alarifi S, Srivastava S Bioengineering (Basel). 2024; 11(8).
PMID: 39199757 PMC: 11352135. DOI: 10.3390/bioengineering11080800.
Roschenko V, Ayoub A, Engelhardt K, Schafer J, Amin M, Preis E Pharmaceutics. 2023; 15(10).
PMID: 37896172 PMC: 10610306. DOI: 10.3390/pharmaceutics15102412.
Tian Y, Zheng Z, Wang X, Liu S, Gu L, Mu J J Nanobiotechnology. 2022; 20(1):318.
PMID: 35794597 PMC: 9258070. DOI: 10.1186/s12951-022-01493-8.